Business · 23/09/1999Updated: 10/17/2026 · 1 min read
FDA Hosts Public Workshop on Developing Standards for Inactivating Infectious Agents in Plasma Derivatives
The US Food and Drug Administration (FDA) is hosting a public workshop to discuss and develop standards for inactivating infectious agents in plasma derivatives manufactured from nonhuman sources for human injectable use
Original source language: Federal Register — Food and Drug AdministrationOpen original release →